Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Marek

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2020
Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-upAndrew Siderowf, Danna Jennings, Matthew Stern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 19, 2007
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's diseaseAndrew Siderowf, Danna Jennings, James Connolly, et al.
Neurology|October 10, 2014
Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome StudyDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
JAMA Neurology|June 9, 2017
Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal CohortDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Neurology|August 1, 2015
Author ResponseDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Journal of Parkinson'S Disease|April 17, 2023
Proposal for a Biologic Staging System of Parkinson's DiseaseLana M Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Annals of Neurology|May 13, 2026
Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers InitiativeDaniel Weintraub, Roseanne D Dobkin, Michele K York, et al.
Journal of Clinical Movement Disorders|January 21, 2016
Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohortMichael S Okun, Samuel S Wu, Dana Jennings, et al.
The Lancet. Neurology|June 14, 2024
Concerns with the new biological research criteria for synucleinopathy - Authors' replyTanya Simuni, Lana M Chahine, Daniel Weintraub, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2011
Serum urate and probability of dopaminergic deficit in early "Parkinson's disease"Michael A Schwarzschild, Kenneth Marek, Shirley Eberly, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Movement Disorders : Official Journal of the Movement Disorder Society|July 14, 2020
Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-upAndrew Siderowf, Danna Jennings, Matthew Stern, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 19, 2007
Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's diseaseAndrew Siderowf, Danna Jennings, James Connolly, et al.
Neurology|October 10, 2014
Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome StudyDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
JAMA Neurology|June 9, 2017
Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal CohortDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Neurology|August 1, 2015
Author ResponseDanna Jennings, Andrew Siderowf, Matthew Stern, et al.
Journal of Parkinson'S Disease|April 17, 2023
Proposal for a Biologic Staging System of Parkinson's DiseaseLana M Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Annals of Neurology|May 13, 2026
Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers InitiativeDaniel Weintraub, Roseanne D Dobkin, Michele K York, et al.
Journal of Clinical Movement Disorders|January 21, 2016
Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohortMichael S Okun, Samuel S Wu, Dana Jennings, et al.
The Lancet. Neurology|June 14, 2024
Concerns with the new biological research criteria for synucleinopathy - Authors' replyTanya Simuni, Lana M Chahine, Daniel Weintraub, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2011
Serum urate and probability of dopaminergic deficit in early "Parkinson's disease"Michael A Schwarzschild, Kenneth Marek, Shirley Eberly, et al.
Pageof 15